MENRAD Andreas

No ORCID on file · 286 papers in corpus · active 2002-2009
2009
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines

VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinamides, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, as well as intermediate products for the production of the c…

2008
Cyanoanthranilamide derivatives and the use thereof as medicaments

Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in …

2008
Cyanoanthranilamide derivatives and the use thereof as medicaments

Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in …

2008
Cyanoanthranilamide derivatives and the use thereof as medicaments

Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in …

2008
Cyanoanthranilamide derivatives and the use thereof as medicaments

Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in …

2008
Cyanoanthranilamide derivatives and the use thereof as medicaments

Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in …

2008
Cyanoanthranilamide derivatives and the use thereof as medicaments

Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in …

2008
Cyanoanthranilamide derivatives and the use thereof as medicaments

Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in …

2008
Cyanoanthranilamide derivatives and the use thereof as medicaments

Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in …

2008
Cyanoanthranilamide derivatives and the use thereof as medicaments

Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in …

2008
Cyanoanthranilamide derivatives and the use thereof as medicaments

Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in …

2008
Cyanoanthranilamide derivatives and the use thereof as medicaments

Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in …

2008
Cyanoanthranilamide derivatives and the use thereof as medicaments

Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in …

2008
Cyanoanthranilamide derivatives and the use thereof as medicaments

Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in …

2008
N-oxide anthranylamide derivatives and their use as medicaments

Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in…

2008
N-oxide anthranylamide derivatives and their use as medicaments

Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in…

2008
N-oxide anthranylamide derivatives and their use as medicaments

Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in…

2008
N-oxide anthranylamide derivatives and their use as medicaments

Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in…

2008
N-oxide anthranylamide derivatives and their use as medicaments

Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in…

2008
N-oxide anthranylamide derivatives and their use as medicaments

Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in…

2008
N-oxide anthranylamide derivatives and their use as medicaments

Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in…

2008
N-oxide anthranylamide derivatives and their use as medicaments

Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in…

2008
N-oxide anthranylamide derivatives and their use as medicaments

Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in…

2008
N-oxide anthranylamide derivatives and their use as medicaments

Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in…

2008
N-oxide anthranylamide derivatives and their use as medicaments

Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in…